MA33231B1 - BIOVERRE-BASED MACROPOROUS CEMENTS, BIOACTIVE, BIORESORBABLE FOR BIOMEDICAL USE - Google Patents

BIOVERRE-BASED MACROPOROUS CEMENTS, BIOACTIVE, BIORESORBABLE FOR BIOMEDICAL USE

Info

Publication number
MA33231B1
MA33231B1 MA33191A MA33191A MA33231B1 MA 33231 B1 MA33231 B1 MA 33231B1 MA 33191 A MA33191 A MA 33191A MA 33191 A MA33191 A MA 33191A MA 33231 B1 MA33231 B1 MA 33231B1
Authority
MA
Morocco
Prior art keywords
cements
bioverre
bioresorbable
bioactive
biomedical use
Prior art date
Application number
MA33191A
Other languages
Arabic (ar)
French (fr)
Inventor
Chaair Hassan
Chroqui Wafaa
Digua Khalid
Sallek Brahim
Bouayad Hassan
Rifki Chouaib
Original Assignee
Univ Hassan Ii Mohammedia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hassan Ii Mohammedia filed Critical Univ Hassan Ii Mohammedia
Priority to MA33191A priority Critical patent/MA33231B1/en
Priority to PCT/MA2011/000008 priority patent/WO2012039592A1/en
Publication of MA33231B1 publication Critical patent/MA33231B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0052—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with an inorganic matrix
    • A61L24/0063—Phosphorus containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Composite Materials (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE L'ÉLABORATION DES CIMENTS MACROPOREUX À BASE DE BIOVERRES BIOACTIFS, OSTÉOCONDUCTEURS, OSTÉOINDUCTEURS, BIORESORBABLES, ET AYANT LA PROPRIÉTÉ HÉMOSTATIQUE ET UNE VITESSE DE DISSOLUTION ADAPTABLE À CELLE DE LA MÉOFORMATION OSSEUSE, POUR LA RÉPARATION, L'AUGMENTATION ET LA RÉGÉNÉRATION OSSEUSE, ET POUR LE TRAITEMENT DE L'OSTÉOPOROSE ET LE CANCER DE L'OS.THE INVENTION CONCERNS THE PREPARATION OF MACROPOROUS CEMENTS WITH BIIOACTIVE BIOVERTERS, OSTEOCONDUCTIVE, OSTEOINDUCTIVE, BIOREBORN, AND HEMOSTATIC PROPERTY AND A DISSOLUTION SPEED ADAPTABLE TO THAT OF BONE MEOFORMATION, FOR REPAIR, INCREASE AND REGENERATION BONE, AND FOR THE TREATMENT OF OSTEOPOROSIS AND BONE CANCER.

MA33191A 2010-09-20 2010-09-20 BIOVERRE-BASED MACROPOROUS CEMENTS, BIOACTIVE, BIORESORBABLE FOR BIOMEDICAL USE MA33231B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA33191A MA33231B1 (en) 2010-09-20 2010-09-20 BIOVERRE-BASED MACROPOROUS CEMENTS, BIOACTIVE, BIORESORBABLE FOR BIOMEDICAL USE
PCT/MA2011/000008 WO2012039592A1 (en) 2010-09-20 2011-09-19 Method for producing macroporous two-phase cement comprising bioglass and an apatite, said cement being bioactive, bioresorbable and suitable for biomedical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA33191A MA33231B1 (en) 2010-09-20 2010-09-20 BIOVERRE-BASED MACROPOROUS CEMENTS, BIOACTIVE, BIORESORBABLE FOR BIOMEDICAL USE

Publications (1)

Publication Number Publication Date
MA33231B1 true MA33231B1 (en) 2012-05-02

Family

ID=44971075

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33191A MA33231B1 (en) 2010-09-20 2010-09-20 BIOVERRE-BASED MACROPOROUS CEMENTS, BIOACTIVE, BIORESORBABLE FOR BIOMEDICAL USE

Country Status (2)

Country Link
MA (1) MA33231B1 (en)
WO (1) WO2012039592A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150283296A1 (en) * 2012-12-18 2015-10-08 Novabone Products Llc Bioactive glass with ethylene oxide proplyene oxide block copolymers
TWI651103B (en) 2013-12-13 2019-02-21 萊特醫技股份有限公司 Multiphase bone graft replacement material
CN105903063B (en) * 2016-05-16 2020-04-21 武汉理工大学 A kind of magnesium-based medical bone cement material and preparation method thereof
US10624994B2 (en) 2017-08-30 2020-04-21 King Abdulaziz University Borate bioactive glass and methods of use for dentin and enamel restoration
US11007299B2 (en) * 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
CN108635624B (en) * 2018-04-25 2022-01-04 武汉理工大学 Anti-collapsibility injectable magnesium phosphate-based bone cement
CN110721346B (en) * 2019-10-30 2020-08-18 中国人民解放军总医院 Biological 3D printing ink and preparation method thereof
US12285540B2 (en) 2020-07-21 2025-04-29 Ethicon, Inc. Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents
CN111773430A (en) * 2020-08-14 2020-10-16 上海长海医院 Vancomycin-loaded hydroxyapatite mesoporous bioglass composite material, preparation method and use
CN116161868A (en) * 2022-12-02 2023-05-26 松山湖材料实验室 Bioactive glass bracket and preparation method and application thereof
CN116813370B (en) * 2023-07-05 2024-04-12 深圳大洲医学科技有限公司 Biological ceramic rod and preparation method and application thereof
CN119112681B (en) * 2024-11-13 2025-03-11 杭州纳美智康科技有限公司 Toothpaste for resisting dentin sensitivity and preparation method thereof, and method for resisting dentin sensitivity
CN120501703B (en) * 2025-07-22 2025-10-24 养系列(山东)生物科技有限公司 Analgesic hemostatic medicament and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880610A (en) 1988-04-20 1989-11-14 Norian Corporation In situ calcium phosphate minerals--method and composition
FR2693716B1 (en) 1992-07-20 1994-10-21 Toulouse Inst Nat Polytech Process for obtaining phosphocalcic hydroxyapatite, applications for bone or dental filling, or molding of parts, and products used.
WO1998016267A1 (en) * 1996-10-15 1998-04-23 University College Dublin Bone replacement materials with interconnecting pore system
FR2830249B1 (en) 2001-10-03 2004-08-13 Toulouse Inst Nat Polytech HYDRAULIC CEMENT COMPOSITION BASED ON CALCIUM CARBONATES
EP1958649A1 (en) 2007-02-14 2008-08-20 Graftys Injectable calcium-phosphate cement releasing a bone resorption inhibitor

Also Published As

Publication number Publication date
WO2012039592A1 (en) 2012-03-29
WO2012039592A8 (en) 2012-05-31

Similar Documents

Publication Publication Date Title
EP2611371A4 (en) ORTHOPEDIC IMPLANT FOR THE TREATMENT OF BONE DEFORMATIONS
EP3852823A4 (en) COMBINED GRAFTS FOR TISSUE REPAIR OR REGENERATION APPLICATIONS
BR112012002124A2 (en) treatment of crohn's disease with laquinimode.
EA201792465A1 (en) CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
HK1206577A1 (en) Fenestrated implant
FR2948016B1 (en) ORTHESIS FOR THE TREATMENT OF RHIZARTHROSIS
EA201491766A1 (en) CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
EA201491412A1 (en) CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
EP2376091A4 (en) NEW TARGETS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
EA201101190A1 (en) A PHARMACEUTICAL COMPOSITION INCLUDING LINAGLIPTIN AND OPTIONAL SGLT2 INHIBITOR AND ITS APPLICATION
BRPI0813563A2 (en) BONE TISSUE IMPLANT UNDERSTANDING STRONIO IONS
EA201390772A1 (en) NEW SALTS AND POLYMORPHIC FORMS OF AFATINIBA
EP2600836A4 (en) CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN
DE502007006879D1 (en) RESERVABLE CALCIUM PHOSPHATE-BASED BIOPOLYMER-NETWORKED BONE REPLACEMENT MATERIAL
WO2012044997A3 (en) Kits, components and methods for tissue reconstruction
MA37506A1 (en) Therapeutic Uses of Fibroblast Growth Factor Proteins 21
EP2828100A4 (en) SURFACE TREATMENT FOR AN IMPLANT SURFACE
EP2528578A4 (en) DENTAL COMPOSITION COMPRISING A CALCIUM SOURCE
CL2008003545A1 (en) Compounds derived from [(imidazol-1-yl) -1-hydroxy-1-phosphono-ethyl] -phosphonic acid; Preparation method; pharmaceutical composition; and use for the treatment of excessive or inappropriate bone resorption or disease caused by excessive preylation of target proteins.
FR2950522B1 (en) ORTHODONTIC WORKING ARC AND ORTHODONTIC TREATMENT SYSTEM COMPRISING THE ARC
MY156897A (en) Ceramic composite for light conversion, method for producing same, and light emitting device including same
EP2134300A4 (en) Calcium phosphate cements comprising autologous bone
FR2993566B1 (en) CHITOSAN HYDROGEL FOR THE REPAIR OF NERVOUS TISSUE
EP3344071A4 (en) COMBINED COMPOSITIONS FOR REGULATING GLYCEMIA LEVELS, HEPATOPROTECTION, AND FOR THE PREVENTION AND TREATMENT OF ASSOCIATED MEDICAL CONDITIONS
EP2445512A4 (en) IMPROVING THE RETENTION OF BONE MORPHOGENETIC PROTEINS (BMP)